{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:16Z","timestamp":1793170036992,"version":"4.5.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugalcdep.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:31:39Z","timestamp":1495672299000},"page":"176-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"special_numbering":"C","title":["Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014Conception and maturation"],"prefix":"10.1016","volume":"178","author":[{"given":"Rebecca","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0005","series-title":"Reducing Drug-related Deaths","author":"ACMD","year":"2000"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0010","series-title":"Consideration of Naloxone","author":"ACMD","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0015","series-title":"Reducing Opioid-Related Deaths in the UK","author":"ACMD","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0020","series-title":"Leben Retten Mit Naloxon","author":"AIDS-Hilfe","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0025","series-title":"AMA Adopts New Policies at Annual Meeting","author":"AMA","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0030","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","article-title":"Project Lazarus: community-based overdose prevention in rural North Carolina","volume":"12","author":"Albert","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)60928-4","article-title":"America embraces treatment for opioid drug overdose","volume":"383","author":"Alcorn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0040","series-title":"AMA and Its Naloxone Policy Position","author":"Anex","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0045","series-title":"Lord Advocate's Guidelines on Allowing the Supply of Naloxone to Extend to Staff Working for Services in Contact with People at Risk of Opiate Overdoses","author":"Angiolini","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/bmj.333.7571.754-a","article-title":"Emergency naloxone for heroin overdose: beware of naloxone's other characteristics","volume":"333","author":"Ashworth","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1360-0443.2005.01259.x","article-title":"Take-home naloxone to reduce heroin death","volume":"100","author":"Baca","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11524-013-9814-y","article-title":"Police officers\u2019 and paramedics\u2019 experiences with overdose and their knowledge and opinions of Washington State\u2019s drug overdose\u2013naloxone\u2013good Samaritan law","volume":"90","author":"Banta-Green","year":"2013","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0065","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.3399\/bjgp17X689857","article-title":"Opiate addiction and overdose: experiences attitudes, and appetite for community naloxone provision","volume":"67","author":"Barry","year":"2017","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1370\/afm.1972","article-title":"Primary care patient experience with naloxone prescription","volume":"14","author":"Behar","year":"2016","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11524-006-9120-z","article-title":"Physicians\u2019 knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities","volume":"84","author":"Beletsky","year":"2007","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1360-0443.1999.94811798.x","article-title":"Accidental overdose among injecting drug users in Dorset, UK","volume":"94","author":"Bennett","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0085","series-title":"Evaluation of the Take Home Naloxone Demonstration Project","author":"Bennett","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0090","first-page":"320","article-title":"The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales","volume":"19","author":"Bennett","year":"2012","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/0959523021000002732","article-title":"Peer overdose resuscitation: multiple intervention strategies and time to response by drug users who witness overdose","volume":"21","author":"Best","year":"2002","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0100","series-title":"Overdose Management Training with Naloxone. Paper Presented at Preventing Heroin Overdose: Pragmatic Approaches. 13\u201314 January","author":"Bigg","year":"2000"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/bmj.324.7338.678","article-title":"Data on take home naloxone are unclear but not condemnatory","volume":"324","author":"Bigg","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11606-015-3394-3","article-title":"Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff","volume":"30","author":"Binswanger","year":"2015","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","article-title":"Male drugs-related deaths in the fortnight after release from prison: scotland, 1996\u201399","volume":"98","author":"Bird","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0120","first-page":"66","article-title":"Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact","volume":"22","author":"Bird","year":"2015","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(17)30656-6","article-title":"Prison-based prescriptions aid scotland's national naloxone programme","volume":"389","author":"Bird","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0135","first-page":"311","article-title":"N-allylnoroxymorphine: a potent narcotic antagonist","volume":"20","author":"Blumberg","year":"1961","journal-title":"Fed. Proc."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0955-3959(01)00080-9","article-title":"Legal aspects of providing naloxone to heroin users in the United States","volume":"12","author":"Burris","year":"2001","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/bmj.333.7571.754","article-title":"Emergency naloxone for heroin overdose: over the counter availability needs careful consideration","volume":"333","author":"Byrne","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5694\/j.1326-5377.1999.tb127675.x","article-title":"Mortality associated with new south wales methadone programs in 1994: lives lost and saved","volume":"170","author":"Caplehorn","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0155","series-title":"Health Canada OK's Non-prescription Nasal Spray Overdose Antidote","author":"CCBCnews","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0160","series-title":"CCENDU Bulletin \u2212 The Availability of Take-Home Naloxone in Canada","author":"CCSA","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0165","first-page":"101","article-title":"Community-based opioid overdose prevention programs providing naloxone-United States, 2010","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb. Mort. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0170","series-title":"Opioid Overdose Prevention Programs Providing Naloxone to Laypersons \u2014 United States, 2014","author":"CDC","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0175","series-title":"MMWR: Increases in Drug and Opioid Overdose Deaths \u2014 United States, 2000\u20132014","author":"CDC","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595239800187551","article-title":"Deaths in the first two weeks of maintenance treatment in NSW in 1994: Identifying cases of iatrogenic methadone toxicity","volume":"17","author":"Caplehorn","year":"1998","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jurban\/jtg031","article-title":"Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City","volume":"80","author":"Coffin P.O., Fuller","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal","volume":"158","author":"Coffin P.O","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3111\/13696998.2013.811080","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities","volume":"16","author":"Coffin","year":"2013","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain \u2212 naloxone coprescribing in primary care clinics","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-158-1-201301010-00013","article-title":"Expanded access to opioid overdose intervention Research, practice, and policy needs","volume":"158","author":"Compton","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0225","series-title":"CRA Annual Report, 2014","author":"CRA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0230","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/add.13429","article-title":"The toxicology of heroin-related death: estimating survival times","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0235","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1360-0443.1997.tb03681.x","article-title":"The distribution of naloxone to heroin users","volume":"92","author":"Darke","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0240","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1360-0443.2003.00474.x","article-title":"The ratio of non-fatal to fatal heroin overdose","volume":"98","author":"Darke","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0245","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.japh.2016.11.007","article-title":"State legal innovations to encourage naloxone dispensing","volume":"57","author":"Davis","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0250","first-page":"e1","article-title":"Expanded access to naloxone among Firefighters, police officers, and emergency medical technicians in Massachusetts","author":"Davis","year":"2014","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0255","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2105\/AJPH.2015.302638","article-title":"Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration","volume":"105","author":"Davis","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0260","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0265","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.322.7291.895","article-title":"Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes","volume":"322","author":"Dettmer","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0270","series-title":"Der Einsatz Von Naloxon Durch Geschulte Laien","author":"Dettmer","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0275","series-title":"The Case for the Wider Distribution of Naloxone in Australia","author":"Dietze","year":"2010"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0280","series-title":"Proceedings of the UNODC Community Management of Opioid Overdose: Development of a Comprehensive Study Protocol","article-title":"Take-home naloxone in Australia","author":"Dietze","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0285","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2458-14-297","article-title":"Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study","volume":"14","author":"Doe-Simkins","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0295","series-title":"Drug Misuse and Dependence- UK Guidelines on Clinical Management","author":"DOH","year":"2007"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0300","series-title":"Attorney General Holder, Calling Rise in Heroin Overdoses \u2018Urgent Public Health Crisis\u2019, Vows Mix of Enforcement, Treatment","author":"DOJ","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0305","series-title":"Preventing Fatal Overdoses: A Systematic Review of the Effectiveness of Take-Home Naloxone","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0310","series-title":"EMCDDA Insights: Preventing Overdose Deaths from Heroin and Other Opioids: Pre-provision of Emergency Naloxone (take-home Naloxone)","author":"EMCDDA","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug-related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0320","series-title":"Preventing Opioid Overdose Deaths \u2212 A Research on the Italian Naloxone Distribution Model","author":"ForumDroghe","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0325","series-title":"Naloxone: Preventing Opioid Overdose Deaths. Foreword","author":"ForumDroghe","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0330","series-title":"Community Development, Priorities, Staged Approach: Implementing Expanded Naloxone Availability in the ACT","author":"Fowlie","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0335","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists' role in opioid overdose: kentucky pharmacists' willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0340","first-page":"1865","article-title":"Naloxone distribution: remembering hepatitis C transmission as an issue","volume":"95","author":"Fry","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0345","series-title":"Role of Naloxone in Opioid Overdose Fatality Prevention","author":"FDA","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0350","series-title":"October 5, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Meeting Announcement","author":"FDA","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0355","first-page":"121","article-title":"The 1982 john scott award goes to jack fishman and harold blumberg for synthesis and investigation of naloxone","volume":"6","author":"Garfield","year":"1983","journal-title":"Essays Inf. Sci."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0360","series-title":"Paper Presented at Preventing Heroin Overdose: Pragmatic Approaches","article-title":"Peer-intervention protocol among young injectors","author":"Giuliano","year":"2000"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0365","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/bmj.313.7054.402","article-title":"Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings","volume":"313","author":"Gossop","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0370","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","article-title":"Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States","volume":"103","author":"Green","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0375","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0017896914550321","article-title":"Development of an incarceration-specific overdose prevention video: staying Alive on the Outside","volume":"74","author":"Green","year":"2015","journal-title":"Health Edu. J."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-015-0058-x","article-title":"Orienting patients to greater opioid safety: models of community pharmacy-based naloxone","volume":"12","author":"Green","year":"2015","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0385","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states","volume":"57","author":"Green","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0390","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/003335490712200313","article-title":"Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City","volume":"122","author":"Heller","year":"2007","journal-title":"Pub. Health Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0395","series-title":"Naloxone for Outpatient Use: Data Required to Support an NDA","author":"Hertz","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0400","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0405","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1377\/hlthaff.2015.0934","article-title":"An overdose antidote goes mainstream","volume":"34","author":"Humphreys","year":"2015","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0410","article-title":"Free condoms should be targeted at people with high STI risk, says NICE","volume":"357","author":"Iacobucci","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0415","series-title":"National Naloxone Programme Scotland: Monitoring Report 2015\/16","author":"ISD","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0420","series-title":"The National Drug-Related Deaths Database (Scotland) Report: Analysis of Deaths Occurring in 2014","author":"ISD","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0425","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2016.303062","article-title":"Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013","volume":"106","author":"Jones","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0430","series-title":"Proceedings of the 2015 APHA Annual Meeting and Expo (Oct 31-Nov 4, 2015)","article-title":"Mapping an opioid overdose prevention program from jail to community","author":"Jordan","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0435","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06550.x","article-title":"Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose","volume":"182","author":"Kelly","year":"2005","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0440","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11524-008-9273-z","article-title":"Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration","volume":"85","author":"Kerr","year":"2008","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0445","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1360-0443.2009.02724.x","article-title":"Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose","volume":"104","author":"Kerr","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0450","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","article-title":"Factors associated with participation in an Emergency Department\u2013based take-home naloxone program for at-risk opioid users","volume":"69","author":"Kestler","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0455","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10900-012-9591-7","article-title":"Injection drug users trained by overdose prevention programs: responses to witnessed overdoses","volume":"38","author":"Lankenau","year":"2013","journal-title":"J. Comm. Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0460","first-page":"538","article-title":"Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians","volume":"61","author":"Leece","year":"2015","journal-title":"Can. Fam. Phys."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0465","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5694\/j.1326-5377.2000.tb125633.x","article-title":"Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?","volume":"173","author":"Lenton","year":"2000","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0470","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1465-3362.2009.00125.x","article-title":"Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia","volume":"28","author":"Lenton","year":"2009","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0475","first-page":"1","article-title":"Australia reschedules naloxone for opioid overdose","volume":"4","author":"Lenton","year":"2016","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0480","unstructured":"Lewenstein, M.J., Fishman, J., 1966. Morphine derivative. US patent 3,254,088 (issued 31 May)."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2017.05.001_bib0485","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.drugalcdep.2016.08.643","article-title":"Prescription opioid addiction and chronic pain: more than a feeling","volume":"173","author":"Ling","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0490","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7517-6-26","article-title":"Can we prevent drug related deaths by training opioid users to recognize and manage overdoses","volume":"6","author":"Lopez-Gaston","year":"2009","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0495","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2016.12.013","article-title":"Rapid widespread distribution of intranasal naloxone for overdose prevention","volume":"173","author":"Madah-Amiri","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0500","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/10826080701801261","article-title":"Evaluation of a naloxone distribution and administration program in New York City","volume":"43","author":"Markham-Piper","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.11.015","article-title":"Experiences of peer-trainers in a take-home naloxone program: results from a qualitative study","volume":"41","author":"Marshall","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2296-15-12","article-title":"Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice","volume":"15","author":"Matheson","year":"2014","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0515","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2010.09.008","article-title":"Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging","volume":"22","author":"Mayet","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0520","first-page":"388","article-title":"Responsible management and use of a personal take-home naloxone supply: a pilot project","volume":"17","author":"McAuley","year":"2010","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0525","first-page":"309","article-title":"From evidence to policy: the Scottish national naloxone programme","volume":"19","author":"McAuley","year":"2012","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0530","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.drugpo.2015.09.011","article-title":"Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users","volume":"26","author":"McAuley","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0535","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.drugalcdep.2016.02.031","article-title":"Engagement in a National Naloxone Programme among people who inject drugs","volume":"162","author":"McAuley","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0540","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/add.13602","article-title":"Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis","volume":"112","author":"McAuley","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0545","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0550","series-title":"Integrated Approaches to Drug and Alcohol Problems: Action on Addiction","article-title":"Reducing deaths from opiate overdose: take-home-naloxone","author":"McDonald","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0555","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1360-0443.1998.9357016.x","article-title":"Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions","volume":"93","author":"McGregor","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0560","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0565","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1360-0443.2012.04066.x","article-title":"A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996\u20132006","volume":"108","author":"Merrall","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0570","series-title":"Proposal to Allow Wider Access to Naloxone for Use in Emergencies","author":"MHRA","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0575","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/add.13027","article-title":"Naloxone\u2014does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","volume":"110","author":"Neale","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0580","series-title":"NICE Guideline [NG68]: Sexually Transmitted Infections: Condom Distribution Schemes","author":"NICE","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0585","series-title":"Legal Interventions to Reduce Overdose Mortality: Naloxone Access and Overdose Good Samaritan Laws","author":"NPHL","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0590","series-title":"Legal Interventions to Reduce Overdose Mortality: Naloxone Access and Overdose Good Samaritan Laws","author":"NPHL","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0595","series-title":"The NTA Overdose and Naloxone Training Programme for Families and Carers","author":"NTA","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0600","series-title":"A.G. Schneiderman Announces More Than 100 Lives Saved By Community Overdose Prevention (COP) Program","author":"NYAG","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0605","series-title":"National Drug Control Strategy","author":"ONDCP","year":"2010"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0610","series-title":"Deaths Related to Drug Poisoning in England and Wales: 2015 Registrations","author":"ONS","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0615","series-title":"Widening the Net of Naloxone Prescribers \u2212The Standing Order Model","author":"OSF","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0620","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/add.13668","article-title":"Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths","volume":"112","author":"Parmar","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0625","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amepre.2006.08.017","article-title":"Opioid analgesics and rates of fatal drug poisoning in the United States","volume":"31","author":"Paulozzi","year":"2006","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0630","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.japh.2017.01.001","article-title":"Strategies and policies to address the opioid epidemic: a case study of Ohio","volume":"57","author":"Penm","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0635","series-title":"Take-home Naloxone for Opioid Overdose in People Who Use Drugs","author":"PHE","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0640","series-title":"Widening the Availability of Naloxone","author":"PHE","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0645","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","article-title":"Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths","volume":"33","author":"Rando","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0650","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.11.008","article-title":"Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study","volume":"108","author":"Ravndal","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0655","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2014.10.026","article-title":"Police officer attitudes towards intranasal naloxone training","volume":"146","author":"Ray","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0660","series-title":"Proceedings of the 2015 APHA Annual Meeting and Expo (Oct 31\u2013Nov 4, 2015)","article-title":"Overdose prevention training at the Rikers Island visit house: a novel approach to targeting a high risk population","author":"Rosner","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0665","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.resuscitation.2011.06.027","article-title":"Prehospital treatment of opioid overdose in Copenhagen\u2014is it safe to discharge on-scene?","volume":"82","author":"Rudolph","year":"2011","journal-title":"Resuscitation"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0670","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2016.03.011","article-title":"An initial evaluation of law enforcement overdose training in Rhode Island","volume":"162","author":"Saucier","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0675","first-page":"895","article-title":"Take home naloxone: a contribution for ongoing debate","volume":"322","author":"Schifano","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0680","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2105\/AJPH.91.11.1842","article-title":"Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998\u20131999","volume":"91","author":"Seal","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0685","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jurban\/jtg032","article-title":"Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area","volume":"80","author":"Seal","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0690","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jurban\/jti053","article-title":"Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study","volume":"82","author":"Seal","year":"2005","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0695","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","article-title":"Mortality from overdose among injecting drug users recently released from prison: database linkage study","volume":"316","author":"Seaman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0700","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7517-5-2","article-title":"A qualitative study of overdose responses among Chicago IDUs","volume":"5","author":"Sherman","year":"2008","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0705","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugpo.2008.02.004","article-title":"The life they save may be mine: diffusion of overdose prevention information from a city sponsored programme","volume":"20","author":"Sherman","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0710","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(05)61528-0","article-title":"BOLOGNA Naloxone supplied to Italian heroin addicts","volume":"352","author":"Simini","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0715","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.annemergmed.2006.05.025","article-title":"Prescription naloxone: a novel approach to heroin overdose prevention","volume":"49","author":"Sporer","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0720","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.304.6835.1127","article-title":"Harm minimisation for drug misusers","volume":"304","author":"Strang","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0725","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.312.7044.1435","article-title":"Heroin overdose: the case for take-home naloxone","volume":"312","author":"Strang","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0730","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1360-0443.1997.tb02927.x","article-title":"Heroin smoking by \u2018chasing the dragon\u2019: Origins and history","volume":"92","author":"Strang","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0735","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","article-title":"Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability","volume":"94","author":"Strang","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0740","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0955-3959(00)00070-0","article-title":"Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation","volume":"11","author":"Strang","year":"2000","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0745","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study","volume":"326","author":"Strang","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0750","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.333.7569.614","article-title":"Emergency naloxone for heroin overdose: should it be available over the counter?","volume":"333","author":"Strang","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0755","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2008.02314.x","article-title":"Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses","volume":"103","author":"Strang","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0760","first-page":"211","article-title":"Family carers and the prevention of heroin overdose deaths: unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone","volume":"15","author":"Strang","year":"2008","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0765","first-page":"1","article-title":"Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial","author":"Strang","year":"2013","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0770","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6580","article-title":"Take-home emergency naloxone to prevent deaths from heroin overdose","volume":"349","author":"Strang","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0775","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2016.02.042","article-title":"Naloxone without the needle-systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal","volume":"163","author":"Strang","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0780","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/add.13209","article-title":"Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?","volume":"111","author":"Strang","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0785","series-title":"3rd International Harm Reduction Conference","article-title":"Harm reduction: defining the concept, exploring the boundaries, and identifying operational possibilities","author":"Strang","year":"1992"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0790","series-title":"Psychoactive Drugs and Harm Reduction: From Faith to Science","article-title":"Drug use and harm reduction: responding to the challenge","author":"Strang","year":"1993"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0795","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1360-0443.1999.9421993.x","article-title":"Take-home naloxone: the next steps. Comments on Strang et al.\u2019s \u2018Preventing opiate overdose fatalities with take-home naloxone pre-launch study of possible impact and acceptability\u2019","volume":"94","author":"Strang","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0800","first-page":"935","article-title":"Take-home naloxone for opiate addicts: author\u2019s reply","volume":"323","author":"Strang","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0805","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/add.13467","article-title":"Commentary on Darke and Duflou (2016): heroin-related deaths: identifying a window for intervention","volume":"111","author":"Tas","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0810","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jurban\/jti052","article-title":"Attitudes of emergency medical service providers toward naloxone distribution programs","volume":"82","author":"Tobin","year":"2005","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0815","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugpo.2008.03.002","article-title":"Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives","volume":"20","author":"Tobin","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0820","first-page":"895","article-title":"Take home naloxone: life-saving intervention, medico-legal concern and heroin users' competence","volume":"322","author":"Trujols","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0825","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/09540121.2016.1189999","article-title":"Is cost a structural barrier preventing men who have sex with men accessing condoms? A systematic review","volume":"28","author":"Ubrihien","year":"2016","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0830","series-title":"90\u201390\u201390 \u2212 An Ambitious Treatment Target To Help End The AIDS Epidemic","author":"UNAIDS","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0835","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0840","series-title":"Resolution 55\/7","author":"UNODC","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0845","series-title":"Informal Scientific Network Statement: United Nations General Assembly Special Session on Drugs (UNGASS 2016)","author":"UNODC","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0850","series-title":"World Drug Report 2016","author":"UNODC","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0855","series-title":"Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality","author":"UNODC\/WHO","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0860","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain \u2014 Misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0865","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA","volume":"21","author":"Wagner","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0870","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.05.008","article-title":"Training law enforcement to respond to opioid overdose with naloxone Impact on knowledge, attitudes, and interactions with community members","volume":"165","author":"Wagner","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0875","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0880","series-title":"Comparative Table of Core and Complementary Medicines on the WHO Essential Medicines List from 1977- 2011","author":"WHO","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0885","series-title":"Community Management of Opioid Overdose","author":"WHO","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0890","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/add.12360","article-title":"Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes","volume":"109","author":"Williams","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.05.001_bib0895","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-7517-3-19","article-title":"Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study","volume":"3","author":"Worthington","year":"2006","journal-title":"Harm Reduct. J."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:50:29Z","timestamp":1602147029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":179,"alternative-id":["S0376871617302120"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014Conception and maturation","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}